Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erfan Komijani"'
Autor:
Amin Daei Sorkhabi, Erfan Komijani, Aila Sarkesh, Pedram Ghaderi Shadbad, Ali Aghebati-Maleki, Leili Aghebati-Maleki
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-21 (2023)
Abstract Beyond the encouraging results and broad clinical applicability of immune checkpoint (ICP) inhibitors in cancer therapy, ICP-based immunotherapies in the context of autoimmune disease, particularly multiple sclerosis (MS), have garnered cons
Externí odkaz:
https://doaj.org/article/8e2c4e3669b74e2fa5ec3e3532d28af7
Autor:
Erfan Komijani, Masoud Delashoub
Background: Sorafenib chemotherapy drug can fight renal cell carcinoma (RCC) cells, the most common kidney cancer, by preventing cell migration and viability and stimulating apoptosis. In recent years, studies on combination therapies in cancer have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4a5bf6c488442060c4e799b1ddc0e09
https://doi.org/10.21203/rs.3.rs-2622044/v1
https://doi.org/10.21203/rs.3.rs-2622044/v1